European Commission Spokesperson Enrico Brivio recently told EURACTIV that the EU executive “took notice” of ECHA’s opinion, which was “based on scientific evidence”.
“The submission of the final opinion to the Commission is expected before the summer break […] After submission of the final opinion, the Commission Services will re-start their discussions with the member states as regards the approval of glyphosate as an active substance in Plant Protection Products (PPPs).”
“A decision has to be taken within 6 months of receipt of the RAC Opinion from ECHA, or by the end of 2017 – at the latest,” he added.
An EFSA spokesperson said, after this article was published, that "EFSA is the first to defend the importance of reliable science as it forms the basis of all our risk assessments", adding "from an initial glance at the "Purchased Science" report, it is clear that the majority of mentioned studies were published after EFSA had completed its assessment of glyphosate. In other words, they did not play any role in the EFSA assessment of glyphosate".
"There are two scientific reviews mentioned in the report (Williams et al 2000, Kier and Kirkland 2013) that were among the 700 references considered in the EU assessment for glyphosate. EFSA and EU member states rely primarily on the original studies and the underlying raw data which they check themselves. The weight given to reviews of scientific studies (like the ones mentioned in the report) is limited," they added.
"There are no grounds to suggest that reviews of scientific studies, sponsored directly or indirectly by industry, improperly influenced the EU risk assessment for glyphosate," the spokesperson concluded.